Article
Testing patterns, patient and tumour characteristics and survival by NRAS and KIT genotype in melanoma.
Clinical and experimental dermatology - 26 Mar 2026
Mistry Khaylen, Jeffrey Polly, Levell Nick J, Kennedy Oliver, Richardson Kathryn, Craig Paul, Bright Chloe, Taylor Siobhan, Ragan John, Karponis Dimitrios, Pethick Joanna, Lavelle Katrina, McRonald Fiona, Hardy Steven, Vernon Sally, Dawe Robert, Proby Charlotte, Lorigan Paul, Venables Zoe C
Abstract excerpt
BACKGROUND: NRAS and KIT mutations in melanoma bring implications for prognosis, follow-up, selection into trials and potential future treatment with targeted therapies. The frequency of NRAS/KIT mutations and their association with patient/tumour characteristics and survival is poorly documented. OBJECTIVES: To report national data from England on (i) the frequency of NRAS and KIT mutations, (ii) the association...
Topics
- Humans
- Melanoma
- Proto-Oncogene Proteins c-kit
- Female
- Male
- Membrane Proteins
- GTP Phosphohydrolases
- Retrospective Studies
- Middle Aged
